|Videos|October 26, 2022
FDA fluorouracil warning, Fetch San Diego, and more
Author(s)dvm360 Staff
Plus, Med Dimensions named Pet Startup of the Year
Advertisement
Advertisement
This content is sponsored by Jaguar Health.
Check out the latest news and analysis on dvm360 Live!™ with host Adam Christman, DVM, MBA. Christman shares what's new in veterinary medicine and important headlines throughout the industry.
Here are the news items covered in the show. See the video for more:
FDA warns pet owners about fluorouracil risks : This topical drug for humans is a deadly threat to petsRegister now for Fetch San Diego : Conference runs December 2-4, 2022Med Dimensions named “Pet Start Up of the Year” in 2022 Pet Independent Innovation Awards program : Med Dimensions recognized for its innovative 3D pre-operative models transforming veterinary medicine
Advertisement
Related to this article
The latest products and innovative technology in veterinary medicine.
The Positive Preventive Veterinary Experience Protocol approach combines environmental changes, pain-reduction techniques, sensory distraction, and positive reinforcement to make preventive visits less stressful for pets and their owners.
Acute diarrhea is a daily reality in general practice—and a stressful one for pet owners.
A technician’s approach to veterinary trauma
dvm360's Australian correspondent Phil Tucak, BSc, BVMS, reports on the success of the new membership model at the Australian Veterinary Association, and reforms to the veterinary regulatory framework in New South Wales.
A new cost analysis finds that matching relapsed lymphoma treatment to a personalized drug-response test was associated with longer disease control and a lower estimated daily treatment cost in dogs.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited the growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in vivo study in dogs with naturally occurring tumors.
Advertisement
Advertisement
Trending on dvm360
1
Pets may help older adults who live alone stay active and connected, survey finds
2
How a structured, multisensory approach can improve the preventive care experience for pets and clients
3
Outpatient surgery for animals with pyometra provides good outcome for dogs and cats
4
Q&A Stuck in the red zone? How veterinary teams can reset after conflict
5